Premium API CagriSema With addition of cagrilintide(a long-acting amylin analog) to semaglutide, CagriSema provides better efficacy than semaglutide(Ozempic, Wegovy) and tirzepatide(Mounjaro, Zepbound) for both obesity and T2DM
For context, the FDA-approved finished drug versions of semaglutide include brand names like Ozempic and Wegovy (registered trademarks of Novo Nordisk), and the FDA-approved finished drug versions of tirzepatide include Zepbound and Mounjaro (registered trademarks of Eli Lilly)
Kate Good Weightloss & Aesthetics we offer a full array of services to help you feel and look your best
CrossRef Multimodal feature fusion with GMM-filtered radiomics for predicting early HCC recurrence Yuting Li, Zhen Wang, Zhenhu He, Chenhong Guo, Jiahao Liu, Zhenwei Peng, Ruhan Liu, Pengfei Rong The Visual Computer .2026;[Epub] CrossRef Artificial Intelligence in Oncology: A Comprehensive Cross-Cancer Translational Readiness Analysis Across 18 Malignancies Sai Kiran Kuchana, Uday Kumar Repalle, Nikhilesh V